Meeting
2016 ASCO Quality Care Symposium
Current landscape of prostate cancer quality measures in the United States.
Authors
Scott C Flanders
Astellas Pharma Global Development, Inc., Northbrook, IL
Scott C Flanders, Eleanor Fitall, Dayo Jagun, Kristi Mitchell, Peter St. John Francis, Hong Tang, Kyung Min Song
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Science of Quality
Track
Cost, Value, and Policy in Quality,Practice of Quality,Science of Quality
Sub Track
Quality Measurement
Citation
J Clin Oncol 34, 2016 (suppl 7S; abstr 273)
DOI
10.1200/jco.2016.34.7_suppl.273
Abstract #
273
Poster Bd #
L1
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Hierarchical clustering analysis for predicting 30-day readmissions after major surgery for prostate cancer.
First Author: Atulya Aman Khosla
Poster
2017 Genitourinary Cancers Symposium
Treatment utilization patterns for prostate cancer (PCa): An analysis from the National Cancer Database (NCDB).
First Author: Jeanny B. Aragon-Ching
Poster
2014 Genitourinary Cancers Symposium
The PROFILE feasibility study: Genetic prostate cancer risk stratification for targeted screening.
First Author: Christos Mikropoulos
Poster
2013 ASCO Annual Meeting
Profile study: Genetic prostate cancer risk stratification for targeted screening.
First Author: Elena Castro